Early Automated Insulin Delivery (AID) Pilot for Newly Diagnosed T1D

Early AID Pilot for Newly Diagnosed T1D

Type 1 diabetes is a common chronic medical condition among youth in the US that requires intensive glycemic management to prevent long-term morbidity and mortality. Current pediatric diabetes care in the US underutilizes automated insulin delivery (AID) systems, which are the best available tools for promoting tight glycemic control while reducing user burden. This proposal aims to support early and sustained use of AID systems by examining and optimizing conditions, evaluating glycemic outcomes, and identifying contextual facilitators and barriers of implementation.

Inclusion Criteria:

• Recent clinical diagnosis of type 1 diabetes within the past 2 weeks
• intent to follow at Stanford Children's Pediatric Diabetes Clinic for clinical care

Exclusion Criteria:

• Does not have a clinical diagnosis of Type 1 diabetes
• Does not follow at Stanford Children's Pediatric Diabetes Clinic for clinical care